Losartan recall fda 2020 september. FDA Alert: Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP

losartan recall fda 2020 september

As always, Teva and Golden State Medical Supply will continue to partner with, and regularly update, all relevant stakeholders, including regulatory authorities, to resolve this situation. Customers and patients with medical-related questions, who wish to report an adverse event, or quality issues about the Teva products being recalled under the Golden State Medical Supply label should contact Teva Medical Information by phone at: 888-838-2872, option 3, then, option 4. Authored by: Between July 2018 and September 2019, the U. If your case is considered viable, the law firm will provide information about moving forward with your case. Six Additional Lots of Losartan Tablets Recalled.

Next

Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan

losartan recall fda 2020 september

To date, Camber has not received any reports of adverse events related to this recall. Health care professionals and patients should check this statement frequently for any updates. If a manufacturer detects a new impurity or higher level of impurities, they should fully evaluate the impurities and take action to ensure the product is safe for patients. Two of these companies, A-S Medication and RemedyRepack, may also distribute valsartan products not affected by the recall. The agency also updated the valsartan products under recall.

Next

FDA again expands recall for blood pressure drug losartan

losartan recall fda 2020 september

If you are taking a valsartan product, be sure to check to back as the lists may change. Macleods is arranging for return of all recalled products to Qualanex. What Losartan Has Been Recalled? In fact, many valsartan lawsuits are now being consolidated into. Brand names include Atacand, Avapro, Benicar, Cozaar, Diovan, Micardis, and Teveten. We will post the method when it is available.

Next

Recall Expanded for Losartan Potassium Tablets

losartan recall fda 2020 september

To date, Teva has not received any reports of adverse events related to the lots being recalled. The agency updated the list of accordingly. The agency will use the interim limits to recommend manufacturers conduct a voluntary recall if laboratory testing confirms the presence of nitrosamine impurities in finished drug product. Losartan Potassium was distributed by pharmacies nationwide. Evidence shows that all three compounds promote tumor growth in animals. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products.

Next

FDA expands recall of blood pressure meds due to cancer

losartan recall fda 2020 september

They can provide you with information about the proper disposal of the recalled drug. Certain irbesartan products labeled as Westminster Pharmaceuticals Inc. The bulk tablet lots were repackaged into 44 finished products lots for further distribution by Golden State Medical Supply under its product label. The heartburn drug Zantac and several generic versions of the drug were recalled due to contamination in September 2019. Patients may have returned medication unnecessarily if their supply was not part of a recall, but they were unsure.

Next

Losartan

losartan recall fda 2020 september

It can also be found in generic forms. When a defect in the manufacturing process occurs, like what has happened with the Losartan contamination, the results can be deadly and result in prolonged suffering and financial burdens. The legal forms on this website are secure and protect the of your information. A study of more than 5,000 patients taking the drugs showed they were not more likely to develop cancer in the short term. The recall was prompted by the discovery of cancer-causing impurities in the medications.

Next